To explore the complex dual role of estrogen in renal physiology and pathology, emphasizing the significance of precision modulation strategies in addressing its protective and detrimental effects in kidney disease.
Approach:
Key Findings:
Estrogen has protective effects against CKD through anti-inflammatory, anti-fibrotic, and hemodynamic pathways.
Sexual dimorphism influences the renal effects of estrogen, with premenopausal women showing slower CKD progression.
Estrogen levels and exposure duration correlate with CKD risk, particularly in perimenopausal women.
Under certain pathological conditions, estrogen may exacerbate kidney disease progression, necessitating careful consideration in treatment.
Interpretation:
The dual role of estrogen in kidney disease necessitates a deeper understanding of its mechanisms to develop targeted therapies and precision modulation strategies, highlighting the urgency for clinical applications.
Limitations:
The precise mechanisms of estrogen's effects in different renal conditions remain poorly defined, particularly in relation to specific disease contexts.
Further high-quality experimental studies are needed to elucidate estrogen synthesis and metabolism in the kidney, focusing on diverse renal conditions.
Conclusion:
A systematic understanding of estrogen's dual role in kidney disease is essential for guiding future research and clinical applications, particularly in the context of precision medicine.
